Seretis, F.; Glava, C.; Smparounis, S.; Riga, D.; Karantzikos, G.; Theochari, M.; Theodorou, D.; Triantafyllou, T.
Tumor-Infiltrating Lymphocytes in Resected Esophageal and Gastric Adenocarcinomas Do Not Correlate with Tumor Regression Score After Neoadjuvant Chemotherapy: Results of a Case-Series Study. Cancers 2024, 16, 3694.
https://doi.org/10.3390/cancers16213694
AMA Style
Seretis F, Glava C, Smparounis S, Riga D, Karantzikos G, Theochari M, Theodorou D, Triantafyllou T.
Tumor-Infiltrating Lymphocytes in Resected Esophageal and Gastric Adenocarcinomas Do Not Correlate with Tumor Regression Score After Neoadjuvant Chemotherapy: Results of a Case-Series Study. Cancers. 2024; 16(21):3694.
https://doi.org/10.3390/cancers16213694
Chicago/Turabian Style
Seretis, Fotios, Chrysoula Glava, Spyridon Smparounis, Dimitra Riga, Georgios Karantzikos, Maria Theochari, Dimitrios Theodorou, and Tania Triantafyllou.
2024. "Tumor-Infiltrating Lymphocytes in Resected Esophageal and Gastric Adenocarcinomas Do Not Correlate with Tumor Regression Score After Neoadjuvant Chemotherapy: Results of a Case-Series Study" Cancers 16, no. 21: 3694.
https://doi.org/10.3390/cancers16213694
APA Style
Seretis, F., Glava, C., Smparounis, S., Riga, D., Karantzikos, G., Theochari, M., Theodorou, D., & Triantafyllou, T.
(2024). Tumor-Infiltrating Lymphocytes in Resected Esophageal and Gastric Adenocarcinomas Do Not Correlate with Tumor Regression Score After Neoadjuvant Chemotherapy: Results of a Case-Series Study. Cancers, 16(21), 3694.
https://doi.org/10.3390/cancers16213694
